A randomised trial of intravesical irrigation in superficial bladder cancer followed by treatment with epodyl or mitomycin C at the time of first recurrence

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN88118697

Enrollment

1000

Registered

2001-03-13

Start date

1987-07-01

Completion date

Unknown

Last updated

2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer Cancer Malignant neoplasm of bladder

Interventions

Epodyl or mitomycin C Follow-up: 3 monthly for 1st year, 6 monthly for 2nd year, annually thereafter.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed superficial bladder cancer suitable for complete endoscopic resection 2. Transitional cell carcinoma limited to the bladder, no evidence of carcinoma in the upper tracts 3. World Health Organisation (WHO) performance status 0-2 4. Expected survival at least 3 years 5. White count greater than 3 x 10^9/L and platelets greater than 100 x 10^9/L 6. No untreated urinary tract infection

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Recurrence free survival	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026